NYSE · STVN
Stevanato Group S.p.A.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for STVN: Nov 03, 2026
Stevanato Group S.p.A. Ordinary Shares is expected to report earnings on 11/03/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $0.17. The reported EPS for the same quarter last year was $0.16.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.17 | $0.18 | $0.16 | 3 |
| Dec 2026 | $0.23 | $0.24 | $0.23 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
BNK Invest · Zacks · MarketBeat · The Motley Fool- BNK Invest · Oct 8, 4:41 PM EDTStevanato Group is Now Oversold (STVN)Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
- Zacks · Oct 1, 6:02 AM EDTUnited Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last?United Therapeutics (UTHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- Zacks · Sep 18, 9:09 AM EDTelectroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?electroCore (ECOR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- MarketBeat · Aug 9, 4:03 AM EDTStevanato Group Q2 Earnings Call Highlights3 Newly Public Stocks Notching Solid 2021 GrowthStevanato Group (NYSE:STVN) reported second-quarter 2026 revenue growth of 8% as demand for higher-value drug containment and delivery products helped lift profitability, while the company updated its full-year outlook to reflect th
- Zacks · Aug 5, 12:45 PM EDTIs Stevanato (STVN) a Solid Growth Stock? 3 Reasons to Think "Yes"Stevanato (STVN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- The Motley Fool · Aug 4, 10:41 PM EDTStevanato (STVN) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 4, 7:50 AM EDTStevanato Group (STVN) Q2 Earnings Top EstimatesStevanato (STVN) delivered earnings and revenue surprises of +6.67% and -0.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 29, 8:25 AM EDTIonis Pharmaceuticals (IONS) Reports Q2 Loss, Tops Revenue EstimatesIonis Pharmaceuticals (IONS) delivered earnings and revenue surprises of +51.69% and +40.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 7, 7:38 AM EDTProfound Medical (PROF) Moves 8.2% Higher: Will This Strength Last?Profound Medical (PROF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- Zacks · Jun 23, 7:08 AM EDTAurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?Aurinia (AUPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- The Motley Fool · Jun 9, 11:05 AM EDT2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right NowThe shares of both stocks are down so far this year.
- Zacks · Jun 3, 11:50 AM EDTImplied Volatility Surging for Stevanato Stock OptionsInvestors need to pay close attention to STVN stock based on the movements in the options market lately.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Stevanato Group S.p.A. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.